This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 34943519
Submitted by lobbyist on: November 9, 2017 12:03:03 PM
Accepted by Registrar on: November 9, 2017 12:19:54 PM
Lobbyist Information
| McIntyre, Daniel |
| 65 Queen Street West Suite 2010 | |
|
Toronto , ON, M5H 2M5
|
416-362-6141 |
| Canada |
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbyist Firm Information
| Grosso McCarthy Inc. |
| 65 Queen Street West Suite 2010 | |
|
Toronto , ON, M5H 2M5
|
416-362-6141 |
| Canada |
Client Information
| Bioverativ Canada |
| To advocate for continued patient access to long-acting therapies Eloctate and Alprolix for treatment of Hemophilia A or B. |
| 90 Burnhamthorpe Rd W Suite 11 | |
|
Mississauga, ON, L5B 3C3
|
647-688-1065 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Biogen Canada |
90 Burnhamthorpe Rd W Suite 11
Mississauga, ON L5B 3C3 Canada |
Phone: 905-804-1444 |
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
| November 8, 2017 | |
| May 1, 2018 |
Other Individuals Engaged to Lobby
| McCarthy, Michael |
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder
To advocate for continued patient access to long-acting therapies Eloctate and Alprolix for treatment of Hemophilia A or B.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | November 9, 2017 |